modelS01AA23

Diagram of S01AA23

Extends from Pharmacokinetic.Models.PK_2C.

Information

name:Netilmicin
ATC code:S01AA23
route:intravenous
compartments:2
dosage:150mg
volume of distribution:0.25L
clearance:80ml/min
other parameters in model implementation

Netilmicin is a semisynthetic aminoglycoside antibiotic derived from sisomicin. It is used to treat serious bacterial infections, particularly those caused by Gram-negative bacteria, and is typically reserved for use when other aminoglycosides may not be effective due to resistance. It is primarily administered parenterally due to poor absorption orally. While it has been clinically used in the past, current use is limited due to concerns about nephrotoxicity and ototoxicity, and safer alternatives being available.

Pharmacokinetics

Pharmacokinetic parameters reported for adults with normal renal function following intravenous administration.

References

  1. Jauregizar, N, et al., & Calvo, R (2003). Population pharmacokinetics of netilmicin in short-term prophylactic treatment. British journal of clinical pharmacology 55(6) 552–559. DOI:10.1046/j.1365-2125.2003.01783.x PUBMED:https://pubmed.ncbi.nlm.nih.gov/12814449

  2. Tréluyer, JM, et al., & Pons, G (2000). Population pharmacokinetic analysis of netilmicin in neonates and infants with use of a nonparametric method. Clinical pharmacology and therapeutics 67(6) 600–609. DOI:10.1067/mcp.2000.106695 PUBMED:https://pubmed.ncbi.nlm.nih.gov/10872642

  3. Sherwin, CM, et al., & Reith, DM (2008). Individualising netilmicin dosing in neonates. European journal of clinical pharmacology 64(12) 1201–1208. DOI:10.1007/s00228-008-0536-0 PUBMED:https://pubmed.ncbi.nlm.nih.gov/18685839

Parameters

TypeNameDefaultDescription
Modelica.Units.SI.Massweight (from PK_1C)75patient weight (kg)
Modelica.Units.SI.SpecificVolumeVdPerKg (from PK_1C)0.9Volume of distribution (L/kg)
Modelica.Units.SI.MassFractionF (from PK_1C)0.8bioavailiability (0-1)
Pharmacolibrary.Types.ClearanceCl (from PK_1C)20clearance
Modelica.Units.SI.TimeadminTime (from PK_1C)60first administration time (s)
Modelica.Units.SI.TimeadminDuration (from PK_1C)600administration duration (s)
Modelica.Units.SI.TimeadminPeriod (from PK_1C)8*60*60period of administration (default 8 hours)(s)
Pharmacolibrary.Types.MassadminMass (from PK_1C)1000administration mass (mg)
IntegeradminCount (from PK_1C)8number of dose administered (1)
Pharmacolibrary.Types.VolumeVd (from PK_1C)VdPerKg*weightVolume of distribution (m3)
Pharmacolibrary.Types.MassConcentrationCmin (from PK_1C)0.004minimal therapeutic range
Pharmacolibrary.Types.MassConcentrationCmax (from PK_1C)0.008minimal therapeutic range
Pharmacolibrary.Types.MassConcentrationCtox_peak (from PK_1C)0.012toxicity peak level
Pharmacolibrary.Types.MassConcentrationCtox_trough (from PK_1C)0.006toxicity trough level
Pharmacolibrary.Types.VolumeVdp (from PK_2C)VdpPerKg*weightVolume of distribution (m3)
Modelica.Units.SI.SpecificVolumeVdpPerKg (from PK_2C)0.9Volume of distribution peripheral(l/kg)
Pharmacolibrary.Types.Clearancek12 (from PK_2C)1intercompartmental C-P clearance
Pharmacolibrary.Types.Clearancek21 (from PK_2C)1intercompartmental P-C clearance

Connectors

TypeNameDefaultDescription
Types.ConcentrationOutputC_central (from PK_1C)
Interfaces.ConcentrationPort_bcentralCPort (from PK_1C)
Interfaces.ConcentrationPort_bperipheralCPort (from PK_2C)
Pharmacolibrary.Types.ConcentrationOutputC_peripheral1 (from PK_2C)

Components

TypeNameDefaultDescription
Pharmacokinetic.NoPerfusedTissueCompartmentcentral (from PK_1C)
Pharmacokinetic.ClearanceDrivenEliminationelim (from PK_1C)
Sources.PeriodicDoseperiodicDose (from PK_1C)
Modelica.Units.SI.Timet1_2 (from PK_1C)elimination half-life
Pharmacolibrary.Pharmacokinetic.TransferFirstOrderNonSymtransfer (from PK_2C)
Pharmacolibrary.Pharmacokinetic.NoPerfusedTissueCompartmentperipheral (from PK_2C)

Revisions

  • 06/2025 Tomas Kulhanek, generated model from data extracted from PUBMED, DrugBank and LLM(GPT4.1)